Chesapeake Asset Management Llc
Source: SEC Form 13F · as of Mar 2026Chesapeake Asset Management Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $14.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$14.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 9,310 | $8.6M |
| MRKMerck & Co., Inc. | 15,053 | $1.8M |
| JNJJOHNSON & JOHNSON | 5,925 | $1.4M |
| ABBVAbbVie Inc. | 5,656 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,390 | $647K |
| PMPhilip Morris International Inc | 3,148 | $520K |
| PFEPFIZER INC | 3,972 | $112K |
| MCKMcKesson Corporation | 100 | $87K |
| BMYBRISTOL MYERS SQUIBB CO | 917 | $56K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 63 | $28K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 248 | $14K |
| ABTABBOTT LABORATORIES | 104 | $11K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 3,265 | $10K |
| CRSPCRISPR Therapeutics AG | 200 | $10K |
| GEHCGE HealthCare Technologies Inc. | 117 | $8K |
| ZTSZoetis Inc. | 60 | $7K |
| CLOVClover Health Investments Corp. | 2,400 | $4K |
| DFTXDefinium Therapeutics Inc. | 33 | $623 |
| VTRSViatris Inc | 24 | $324 |
| OGNOrganon & Co. | 30 | $179 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.